Imaging test for liver cancer
Part of Cancer clinical trials.
This study tests a new imaging method that uses a special substance to find liver cancer cells. It may help doctors see if the cancer has come back after treatment, which could guide next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult who can sign a consent form and follow the study rules.
- You have liver cancer (hepatocellular carcinoma) or are suspected of having it, and you are in overall good health.
- If you had liver cancer before and it came back, you may qualify.
- You must be able to lie still for imaging tests (no severe claustrophobia or fear of radiation).
- If you are a woman who can have children, you must use birth control during the study.
- You cannot be pregnant or breastfeeding, and you must not be allergic to the imaging agent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new PET imaging method that targets GPC3, a protein often found in liver cancer cells. It may help doctors see and understand liver cancer better, especially in people with newly diagnosed or recurrent disease.
This trial tests whether a new PET imaging agent (GPC3-targeted) can find liver cancer as well as or better than enhanced MRI. It may help diagnose hepatocellular carcinoma (the most common type of liver cancer) more accurately.
This study tests a new way to take detailed pictures of liver cancer using a special PET/CT scan. The scan aims to help doctors see the cancer more clearly, and your results may help guide your treatment.
This trial tests a new imaging technique that may help doctors see liver cancer more clearly. It uses a special tracer that targets a protein found on many liver cancer cells. This could help with diagnosis and monitoring.
This study tests a new type of PET/CT scan (called PSMA) that may help doctors see liver cancer (HCC) better. The scan takes detailed images to track how the cancer behaves, which could help choose the best treatment.
This study tests a new imaging tracer to better see liver cancer on PET scans, which might help doctors find or monitor tumors more accurately.
Hear when a new HCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.